Levonorgestrel-releasing implants are long acting contraceptives, approved for 5 years of
continuous use. Two marketed systems, the six capsule Norplant® 1 and the two rod …

Progestin-only contraceptives administered by injection (Depo-Provera) or subcutaneous
implant (Norplant) have been available to US women for about a decade. Two …

The metabolic impact of progestin-only contraceptives is less than that of combined oral
contraceptives. Subdermal contraceptive implant systems that provide a sustained release …

OBJECTIVE: Women with diabetes need safe, effective contraception. Although intrauterine
devices provide superior contraception, concerns remain that progestin absorbed …

Subdermal implants are contraceptive systems that release low, stable amounts of synthetic
progestins from Silastic or other materials for periods of months to several years. Unlike …

Levonorgestrel 6-capsule subdermal implants (Norplant®) are an effective form of reversible
contraception. When implanted under the skin of the upper arm, they release drug into the …

The objective of the study was to assess the possible differences in effects of Implanon® and
Norplant® implants on carbohydrate metabolism. This is a 2-year open randomized study of …

The experience of 6 million Norplant users has led to several more advanced implants.
Implanon is a single-rod implant system containing a low androgenic progestin and requires …

PURPOSE: This prospective study aimed to assess the possible effects of the levonorgestrel-
releasing intrauterine system (LNG-IUS) on serum lipids and fasting blood glucose levels …

Objective The use of combined hormonal contraceptives (CHCs) worsens glucose
tolerance, but the risk for glucose metabolism disorders remains controversial. Design The …